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Introduction {#sec1}
============

Mitogen-activated protein kinase (MAPK) kinase (MAP2K) kinases (MAP3Ks) are important regulators of IκB kinases (IKKs) and MAP2Ks ([@bib10], [@bib17], [@bib27], [@bib34], [@bib40]). Nineteen MAP3Ks are present in mammals, though their precise roles in regulating the immune system are not fully understood ([@bib20], [@bib40]). Mek kinase 1 (Mekk1) is unique in containing both a kinase domain and a plant homeodomain (PHD), that can bind transforming growth factor (Tgf)-β-activated kinase 1 (Tak1)-binding protein 1 (Tab1) and act as an E3 ubiquitin (Ub) ligase ([@bib40], [@bib8]). *Map3k1*^*ΔKD*^ B cells regulate Jnk and p38 signaling from tumor necrosis factor (TNF) receptor family members (TNFRs) ([@bib31], [@bib15], [@bib21]). Analysis of *Map3k1*^*ΔKD*^ T cells demonstrated that Mekk1 is an important regulator of T helper 2 (Th2) cytokine production by the Jnk-dependent activation of Itch ([@bib11], [@bib14], [@bib16], [@bib12], [@bib42]). Moreover, an intact Mekk1 PHD motif is required for Itch phosphorylation following T cell receptor (TCR) signaling ([@bib40], [@bib8]), though the means by which Mekk1 is recruited to the TCR remain to be clarified. *Map3k1*^*ΔKD*^ CD8^+^ T cells display enhanced expansion in response to viruses, but the mechanism remains uncertain ([@bib28]). The analysis of the precise role of Mekk1 in T cells using *Map3k1*^*ΔKD*^ mice has been complicated by both B lymphocyte defects and also the partial lethality of *Map3k1*^*ΔKD*^ mice on the C57BL/6 background ([@bib5], [@bib15]).

T lymphocytes form a critical cellular component of the adaptive immune response and can be broadly subdivided into conventional and unconventional subtypes ([@bib25], [@bib43]). Of these, natural killer T (NKT) cells constitute a unique unconventional T cell population of the immune system ([@bib26]). By contrast to conventional CD4^+^ and CD8^+^ T cells, which are reactive to major histocompatibility complex (MHC) class I- or II-associated peptides, NKT cells can recognize lipids in the context of CD1d molecules ([@bib2], [@bib38], [@bib6]). NKT cells may express a skewed range of TCR variable region genes and the natural killer (NK) cell marker NK1.1 ([@bib37]). NKT cells can be subdivided into three categories based on their reactivity to the glycolipid α-galactosylceramide (α-GalCer), TCR α chain diversity, and CD1d dependency. Type I invariant NKT (iNKT) cells have invariant Vα14-Jα18 TCR α chains and react to α-GalCer in a CD1d-dependent manner. Type II nonclassical NKT cells are unreactive to α-GalCer and have TCR α chain diversity but are CD1d dependent. NKT-like (or type III) cells are CD1d independent, unresponsive to α-GalCer, and possess diverse TCR α chains ([@bib3]). Following TCR engagement by glycolipid presented by CD1d, iNKT cells undergo proliferative expansion and secrete cytokines ([@bib22], [@bib9], [@bib33], [@bib18]). Type I iNKT cells are abundant within the liver, where they are important regulators of inflammation and liver damage ([@bib41]).

Here, we investigate *Map3k1* by T-cell-specific and germline ablation in mice. *Map3k1* regulates iNKT cell proliferative expansion in response to glycolipid antigen. CARD-containing MAGUK protein 1 (Carma1), a TCR-associated scaffold protein, is a target for the Mekk1 PHD motif and provides a mechanism for Mekk1 recruitment to the TCR ([@bib4], [@bib35]). Microarray gene profiling of *Map3k1*-deficient iNKT cells undergoing their clonal burst in response to glycolipid antigen identified *Cdkn1b* as a cell-cycle gene that is aberrantly expressed in *Map3k1*-deficient mice ([@bib24]). The regulation of p27^Kip1^ by Mekk1 signaling provides a cell intrinsic molecular explanation for the altered proliferative expansion observed in both *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ iNKT cells.

Results {#sec2}
=======

*Map3k1* Regulates Conventional T Cells {#sec2.1}
---------------------------------------

Because *Map3k1*^*ΔKD*^ mice have both B cell defects and partial lethality on the C57BL/6 background, we generated *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice ([Figures 1](#fig1){ref-type="fig"}A, [S1](#mmc1){ref-type="supplementary-material"}A, and S1B) to better understand the roles of *Map3k1* in T cells ([@bib15], [@bib5]). Within the thymus of *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice, there is a minor development defect with significantly fewer CD4^+^CD8^+^ double-positive thymocytes than WT but a significantly larger than WT population of CD4^+^ single-positive thymocytes ([Figures 1](#fig1){ref-type="fig"}B and 1C; [@bib7], [@bib8]). However, the total number of thymocytes in *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice is similar to WT ([Table S1](#mmc1){ref-type="supplementary-material"}; [@bib16], [@bib42], [@bib28]). Splenic CD4^+^ T cells isolated from *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice display an enhanced production of *Il4* following TCR crosslinking with anti-CD3 and anti-CD28 antibodies ([Figure S1](#mmc1){ref-type="supplementary-material"}C), the same Itch activation-dependent Th2 phenotype observed in *Map3k1*^*ΔKD*^ CD4^+^ T cells ([@bib16], [@bib42]). By contrast, γδ T cells isolated from *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ or WT mice are not significantly different ([Figure S1](#mmc1){ref-type="supplementary-material"}D; [@bib30]). *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice display significantly more CD4^+^ and CD8^+^ T cells within the spleen and liver and a significantly larger CD8^+^ T cell population within the bone marrow ([Figures 1](#fig1){ref-type="fig"}B and 1C; [@bib7], [@bib8]). No significant difference was detected in T cells isolated from the thymus, spleen, liver, or bone marrow between WT and *Lck*^*Cre/+*^ mice ([Figure S1](#mmc1){ref-type="supplementary-material"}E; data not shown).

*Map3k1* Regulates iNKT Cells {#sec2.2}
-----------------------------

*Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice have significantly higher numbers of iNKT cells (CD1d tetramer^+^CD3^+^, CD1d tetramer^+^TCRβ^+^, or CD1d tetramer^+^NK1.1^+^) within the liver, spleen, and bone marrow relative to WT or *Lck*^*Cre/+*^ mice ([Figures 2](#fig2){ref-type="fig"}A--2C, [S2](#mmc1){ref-type="supplementary-material"}A, and S2B; data not shown; [@bib1]). *Map3k1*^*ΔKD*^ mice, which display a germline deletion of the *Map3k1* exons encoding the Mekk1 kinase domain ([@bib16]), similarly displayed significantly higher numbers of iNKT cells (CD1d tetramer^+^CD3^+^, CD1d tetramer^+^TCRβ^+^, or CD1d tetramer^+^NK1.1^+^) in the liver ([Figures 2](#fig2){ref-type="fig"}B and 2C; data not shown). However, iNKT cell development in the thymus is normal for both *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice ([Figure S2](#mmc1){ref-type="supplementary-material"}C).

Mekk1 Regulates TCR-Dependent Jnk Activation in iNKT Cells {#sec2.3}
----------------------------------------------------------

*Map3k1*^*ΔKD*^ iNKT cells were isolated and stimulated in vitro by TCR crosslinking with antibodies ([Figure 3](#fig3){ref-type="fig"}A; [@bib16], [@bib32]). WT iNKT cells display a transient Jnk activation at 10 min that is significantly reduced in *Map3k1*^*ΔKD*^ iNKT cells following TCR crosslinking with antibodies ([Figures 3](#fig3){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}A). Phosphorylation of c-Jun is similarly reduced in *Map3k1*^*ΔKD*^ iNKT and conventional cells following TCR crosslinking with antibodies (data not shown), but there is no significant defect in p38 activation ([Figure S3](#mmc1){ref-type="supplementary-material"}B; [@bib16]). Because Mekk1 binds and ubiquitinates proteins by its PHD motif, we analyzed a comprehensive Mekk1 PHD protein array screen by ingenuity pathway analysis (IPA) bioinformatics to identify hits that are important for TCR signaling and identified Carma1 as a possible Mekk1 PHD substrate ([Figure 3](#fig3){ref-type="fig"}B; [@bib40], [@bib8]). The Mekk1 PHD binds and, in association with Ub-conjugating enzyme E2N (Ube2N), transfers Lys63-linked Ub chains onto Carma1 ([Figures 3](#fig3){ref-type="fig"}C and 3D). Mekk1 and Carma1 transiently co-purify from iNKT cells 10 min following TCR crosslinking ([Figure S3](#mmc1){ref-type="supplementary-material"}C), and endogenous Carma1 is transiently ubiquitinated following TCR crosslinking with antibodies ([Figures 3](#fig3){ref-type="fig"}E and [S3](#mmc1){ref-type="supplementary-material"}D).

*Map3k1* Regulates Splenic and Liver iNKT Cell Expansion {#sec2.4}
--------------------------------------------------------

To assess the role of Mekk1 signaling in iNKT cell responses to antigen, WT, *Map3k1*^*ΔKD*^, and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice were immunized with the iNKT cell TCR agonist α-GalCer ([Figures 4](#fig4){ref-type="fig"} and [S4](#mmc1){ref-type="supplementary-material"}). Short-term stimulation of *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice with α-GalCer lead to normal iNKT activation and cytokine production ([Figure S4](#mmc1){ref-type="supplementary-material"}A; data not shown). By contrast, splenic iNKT cells from *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice display significantly reduced long-term proliferative expansion following immunization with α-GalCer ([Figures 4](#fig4){ref-type="fig"}A, 4B, and [S4](#mmc1){ref-type="supplementary-material"}B; data not shown). Conversely, liver iNKT cells from *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice showed significantly enhanced long-term proliferative expansion following immunization with α-GalCer ([Figures 4](#fig4){ref-type="fig"}C, [S4](#mmc1){ref-type="supplementary-material"}B, and S4C). Analysis of the livers from *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice revealed significantly enhanced lymphocyte infiltration and liver damage following long-term immunization with α-GalCer relative to control mice ([Figures 4](#fig4){ref-type="fig"}D and [S4](#mmc1){ref-type="supplementary-material"}D).

Mekk1 Controls iNKT Cell Proliferative Expansion by the Regulation of Jnk-Dependent p27^Kip1^ Expression {#sec2.5}
--------------------------------------------------------------------------------------------------------

To understand the molecular basis underpinning the aberrant proliferative expansion of both *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ and *Map3k1*^*ΔKD*^ iNKT cells, we analyzed global gene expression patterns following the long-term immunization of *Map3k1*^*ΔKD*^ mice with α-GalCer ([Figure 5](#fig5){ref-type="fig"}A; [Table S2](#mmc1){ref-type="supplementary-material"}). Bioinformatics analysis of the screened hits identified *Cdkn1b* (encoding p27^Kip1^) as a *Map3k1*-dependent cell-cycle regulator ([Figure S5](#mmc1){ref-type="supplementary-material"}A). *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice have enhanced long-term phospho-c-Jun in splenic iNKT cells but reduced phospho-c-Jun in liver iNKT cells, relative to WT following immunization with α-GalCer ([Figure 5](#fig5){ref-type="fig"}B). *Cdkn1b* and p27^Kip1^ expression is significantly enhanced in splenic *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ iNKT cells, but *Cdkn1b* expression is significantly reduced in liver *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ iNKT cells following long-term stimulation by α-GalCer ([Figures 5](#fig5){ref-type="fig"}C and 5D; data not shown). Similarly, other screened hits (including *Rorc*, *Il1β*, *Il1f9*, and *Cxcr2*) identified by global gene expression analysis were verified by real-time PCR in splenic ([Figure S5](#mmc1){ref-type="supplementary-material"}B; data not shown) and liver tissues ([Figure S5](#mmc1){ref-type="supplementary-material"}C; data not shown). Integrin gene expression (*Itgb7*, *Itgb21*, and *Itgb1*) is equivalent between WT and *Map3k1*^*ΔKD*^ iNKT cells ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Whereas splenic iNKT cells from *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice hypoproliferate, splenic *Cdkn1b*^*−/−*^ iNKT cells hyperproliferate following long-term stimulation by α-GalCer ([Figure 5](#fig5){ref-type="fig"}E). iNKT cell proliferation in response to TCR crosslinking with antibodies is significantly reduced by chemical inhibition of Jnk, Ube2N, or cyclin-dependent kinases (CDKs) ([Figure 5](#fig5){ref-type="fig"}F). Splenic, in contrast to liver, *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ iNKT cells display greater phosphorylation of c-Jun at the *Cdkn1b* promoter activator protein-1 (AP-1)-binding site following long-term stimulation by α-GalCer ([Figure 5](#fig5){ref-type="fig"}G; [@bib23]).

Discussion {#sec3}
==========

We have shown, using *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice, that Mekk1 has important roles in T cells. Thymic development is moderately skewed in *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice, with reduced numbers of CD4^+^CD8^+^ double-positive thymocytes and enhanced numbers of CD4^+^ single-positive thymocytes. Our findings differ from *Lck*^*Cre/+*^ *Map3k7*^*f/f*^ mice that display reduced numbers of CD4^+^ and CD8^+^ single-positive thymocytes ([@bib44]) and *Lck*^*Cre/+*^ *Map3k2*^*−/−*^ *Map3k3* ^*f/f*^ mice that display normal thymic development ([@bib7]). The CD4^+^ and CD8^+^ T cell populations are also larger within the spleen, bone marrow, and liver tissues of *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice. *Map3k1*^*ΔKD*^ mice have elevated numbers of T cells in the liver, and analysis of the iNKT cell population revealed that these are significantly expanded in the liver of both *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice. Two factors complicating the analysis of T cells using *Map3k1*^*ΔKD*^ mice have been the germline kinase domain mutation impacting B cells and partial embryonic lethality ([@bib16], [@bib15], [@bib5]). Bone marrow chimeras and in vitro assays using cells from *Map3k1*^*ΔKD*^ mice have previously demonstrated that B and T cell Mekk1 signaling defects are intrinsic ([@bib16], [@bib42], [@bib28], [@bib15]). As such, conditional deletion of *Map3k1* in T cells using *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice represents a significant refinement of the analysis of *Map3k1* in T cells.

TCR signaling leads to the rapid activation of MAPK and the phosphorylation of its downstream targets (e.g., c-Jun), and these can then initiate T cell effector responses ([@bib39], [@bib10]). More recently, E3 Ub ligase Itch was identified as a downstream Mekk1-signaling target that is phosphorylated by Jnk1 to induce a conformational change within the protein leading to Itch activation and canonical ubiquitination of Jun transcription factors ([@bib14], [@bib16], [@bib12], [@bib42]). As with conventional CD4^+^ T cells, TCR signal transduction rapidly activates Jnk in iNKT cells and this is significantly reduced in *Map3k1*-deficent iNKT cells ([@bib16]). Mekk1 transiently binds and ubiquitinates Carma1, a scaffold known to regulate Jnk activation, following TCR engagement, and this provides a mechanism of recruitment for Mekk1 to the TCR that differs from TNFRs or Tgf-β receptors ([@bib40], [@bib8], [@bib13]).

Our work identifies a role for *Map3k1* in the regulation of the iNKT cell proliferative expansion in response to glycolipid antigen. In order to identify the mechanism underpinning *Map3k1*-dependent iNKT cell expansion, we analyzed their global gene expression profile to identify *Cdkn1b* as a regulated target. The modulation of p27^Kip1^ expression in T cells by Mekk1 signaling represents a molecular mechanism that regulates T cell proliferation. We have identified increased iNKT cell infiltration into the liver and a higher degree of liver damage in *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^ *Map3k1*^*f/f*^ mice. The aberrant iNKT cell expansion within the spleen and liver of *Map3k1-*deficient mice can be explained by altered c-Jun-dependent *Cdkn1b* expression. Our results reinforce the importance of Mekk1 signaling in T cells.

Experimental Procedures {#sec4}
=======================

Gene Targeting of *Map3k1* {#sec4.1}
--------------------------

*Map3k1* was targeted by insertion of a *FRT* site followed by a *LacZ* sequence and a *loxP* site into chromosome 13 upstream of the exons of the *Map3k1* gene (to generate the *Map3k1*^*f*^ allele; [@bib36]). The first *loxP* site was followed by *neo* under the control of the human *B-actin* promoter, SV40 poly-A, a second *FRT* site, and a second *loxP* site. A third *loxP* site was inserted downstream of the *Map3k1* exons. *Map3k1*^*+/f*^ ESCs (C57BL/6) were generated by standard procedures ([@bib19]) and genotyped by Southern blotting or genomic PCR ([@bib29], [@bib16], [@bib8]). Four independently generated *Map3k*^*+/f*^ ESC clones were injected into blastocysts, and the resulting transgenics were genotyped by PCR ([@bib16], [@bib8]). Genomic PCR was carried out on mice biopsies using primers to detect the *Map3k1*-specific WT allele, the shorter mutant allele, and the recombinant allele (5′ to 3′ primers: TCGTGGTATCGTTATGCGCC; AATAGGCCACACGTTGACTGG; and CAACCCACGAAAGGAGGTTC; [@bib8]). *Map3k1*^*+/f*^ mice were crossed with *ACTFLPe* mice (Jackson Laboratory) to initiate recombination at the *FRT* sites, deleting the *lacZ* and *neo* and resulting in offspring that contain a *Map3k1*^*f/f*^ allele.

Cell Line and Cell Culture Conditions {#sec4.2}
-------------------------------------

HEK293 cells were maintained in DMEM (22320; Invitrogen) supplemented with 10% FBS (SH3007003; Thermo Scientific) and antibiotics in a humidified atmosphere at 37°C. Cells were passaged every 2 or 3 days when approaching full confluence ([@bib8]).

Transfection {#sec4.3}
------------

HEK293 cells were plated in 6-well plates at a density of 1 × 10^6^ cells per well. The following day, cells were transfected with Lipofectamine 2000 (11668-019; Invitrogen) or Jet Prime (114-07; Polyplus) transfection reagents according to the manufacturer's instructions. Cells were collected and lysed 48 hr later.

Tissue Preparation {#sec4.4}
------------------

Spleen and perfused liver tissues were mashed through a 70-μm and a 100-μm strainer, respectively, and resuspended in RPMI 1640 medium (Invitrogen) supplemented with 10% FBS (ThermoScientific). Following low-speed centrifugation, the splenic pellet was treated with red blood cell (RBC) lysis buffer (Sigma), washed, and resuspended in medium. The liver cell pellet was resuspended in 38% Percoll (GE Healthcare) and then centrifuged at 500 g for 20 min at room temperature. Cell pellets were treated with RBC lysis buffer, washed, and resuspended in medium.

Isolation of iNKT Cells {#sec4.5}
-----------------------

Mouse iNKT cells isolation from spleen or liver tissues was performed using PE-conjugated and α-GalCer-loaded CD1d tetramer ([@bib32]). Tetrameric CD1d:α-GalCer cell complexes were purified using anti-PE MicroBeads (Miltenyi Biotec). Residual B cells were depleted prior to iNKT cell enrichment using a CD45R (B220) MicroBead kit (Miltenyi Biotec), and the final iNKT cell purity obtained was greater than 95%.

Flow Cytometry {#sec4.6}
--------------

Cell staining with CD1d tetramer was followed by intracellular staining performed using a Fix/Perm kit (BD PharMingen). For intracellular staining, the cells were incubated with 50 μg/ml PMA (Sigma-Aldrich), 1 μM ionomycin (Sigma-Aldrich), and 10 μg/ml brefeldin A (Sigma-Aldrich) for 2 hr before processing. For 5-bromo-2-deoxyuridine (BrdU) labeling, mice were fed with BrdU (0.8 mg/ml) in drinking water supplemented with 5% (weight/volume) glucose 1 day prior to α-GalCer (2 μg) i.p. injection. Mice were treated with BrdU in drinking water for 3 days to study proliferation. Cells were surface stained, and BrdU staining was performed according to the manufacturer protocol (BD PharMingen BrdU Flow Kit). Cells were analyzed on a Cyan ADP (DakoCytomation) flow cytometer and further analyzed on a workstation using FlowJo software (TreeStar).

Immunoblotting, Immunoprecipitation, Real-Time PCR, and Chromatin Immunoprecipitation {#sec4.7}
-------------------------------------------------------------------------------------

iNKT cells were isolated by magnetic selection using MACS LS columns according to the manufacturers protocols (Miltenyi Biotech). Immunoblotting (IB) and immunoprecipitation (IP) were carried out as previously described ([@bib16]). iNKT cell RNA was prepared with the RNeasy kit (QIAGEN), and total RNA (500 μg) was converted to cDNA using the High Capacity cDNA RT-Kit (Applied Biosystems). Real-time PCR was performed in triplicate with the appropriate gene primers (Invitrogen; [Table S3](#mmc1){ref-type="supplementary-material"}) using SYBR Green (Applied Biosystems) and an ABI Prism 7700 Sequence Detector (Applied Biosystems). β-actin was used for normalization of results. Chromatin IP (ChIP) was performed using an EpiTect ChIP qPCR primer assay for mouse *Cdkn1b* kit (QIAGEN) according to the manufacturer instructions.

Ubiquitination Assays {#sec4.8}
---------------------

Carma1 cDNA was overexpressed in HEK293 cells and IP performed with anti-FLAG antibody, washed extensively, and protein eluted. Subsequently, Carma1 was incubated for 1 hr at 37°C with the ubiquitination assay enzymes E1 (100 nM), Ube2N:Ub-conjugating enzyme E2 variant 1 (Ube2V1; 0.36 μM), Ub, and ATP, with or without WT Mekk1 PHD (100 ng) or Mekk1 mutant PHD (mPHD; 100 ng; [@bib8]). All ubiquitination assay reagents were from Boston Biochem.

Microarray and Bioinformatics Analysis {#sec4.9}
--------------------------------------

Total RNA from iNKT cells was reverse transcribed into biotinylated cRNA with an RNA amplification kit according to the manufacturer's instructions (Ambion). RNA quality was verified using a 2100 Bioanalyzer (Agilent Technologies). Samples were hybridized to Mouse Gene 1.0 ST arrays (Affymetrix; [@bib8]). Partek software was used according to the vendor protocols for data analysis, quality control, and for creating gene lists and scatterplots. GeneSpringX software was used according to the vendor protocols to generate heatmaps. Probes with a fold change of less than two were discarded. Probes were quantile normalized among all microarray data. Gene lists were uploaded into the IPA program (Ingenuity Systems) to generate relevant signaling networks and gene wheels according to the vendor instructions.

Liver Damage Assay {#sec4.10}
------------------

Mice were injected i.v. with 2 μg KRN7000. After 3 days, the livers were harvested, fixed in 4% paraformaldehyde, processed, and paraffin embedded. H&E staining was carried out on liver sections (4 μm). Slides were analyzed using an Olympus light microscope, and pictures were taken using Image Pro-Software at 40× magnification.

Statistical Analysis {#sec4.11}
--------------------

Data were expressed as SEM. Statistical significance was determined by two-tailed Student's t test. All analyses were performed using GraphPad Prism 5 software (GraphPad).
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![T Cell Development and Homeostasis within *Lck*^*Cre/+*^*Map3k1*^*f/f*^ Mice\
(A) A schematic diagram representing the construction of the *Map3k1*^*f/f*^ allele.\
(B) Thymocytes, splenocytes, bone marrow, and liver cells from WT, *Map3k1*^*ΔKD*^, and *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice (all on the C57BL/6 background) were isolated, stained with anti-CD4 and anti-CD8 antibodies, and analyzed by flow cytometry as indicated. Data are representative of three independent experiments. Numbers in the profiles indicate the percentages of the gated populations.\
(C) The average percentage (±SEM) of three cell populations CD4^+^CD8^+^, CD4^+^CD8^−^, and CD4^−^CD8^+^ cells from *Lck*^*Cre/+*^*Map3k1*^*f/f*^ and WT mice from six independent experiments was statistically analyzed (green circle, CD4^+^CD8^+^; purple square, CD4^+^CD8^−^; blue triangle, CD4^−^CD8^+^), where appropriate, by two-tailed Student's t test (^∗^p ≤ 0.05; ^∗∗^p ≤ 0.01; ^∗∗∗^p ≤ 0.001).](gr1){#fig1}

![iNKT Cell Development and Homeostasis in *Map3k1*^*ΔKD*^ and *Lck*^*Cre/+*^*Map3k1*^*f/f*^ Mice\
(A) Cell suspensions were isolated from the spleen, thymus, bone marrow, and liver from WT, *Map3k1*^*ΔKD*^, and *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice, stained with CD1d tetramer and anti-CD3 antibody, and analyzed by flow cytometry as indicated. Data are representative of five independent experiments. Numbers in the profiles indicate the percentages of the gated populations.\
(B) Statistical analysis of iNKT populations (CD1d tetramer^+^CD3^+^) within the spleen, thymus, bone marrow, and liver from WT, *Map3k1*^*ΔKD*^, and *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice. The average percentage (±SEM) of CD1d-tetramer and CD3-positive cells from five independent experiments is shown (black circle, WT; red square, *Map3k1*^*ΔKD*^; purple triangle, *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice). Statistical differences were analyzed by two-tailed Student's t test (^∗^p ≤ 0.05; ^∗∗^p ≤ 0.01; ^∗∗∗^p ≤ 0.001).\
(C) Statistical analysis of iNKT populations (CD1d tetramer^+^TCRβ^+^) within the spleen, thymus, bone marrow, and liver from WT, *Map3k1*^*ΔKD*^, and *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice. The average percentage (±SEM) of CD1d-tetramer and TCRβ-positive cells from five independent experiments is shown (black circle, WT; green square, *Map3k1*^*ΔKD*^; green triangle, *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice). Statistical differences were analyzed by two-tailed Student's t test (^∗^p ≤ 0.05; ^∗∗^p ≤ 0.01; ^∗∗∗^p ≤ 0.001).](gr2){#fig2}

![*Map3k1* Regulates Jnk Activation in iNKT Cells\
(A) iNKT cells were isolated (four mice per experiment) and stimulated by TCR crosslinking with antibodies over a 240-min time course as indicated. Cell lysates were made and analyzed by IB with the indicated antibodies. Arrowhead indicates phospho-p38 and asterisk a non-specific band.\
(B) IPA network diagram of TCR signaling to show the presence of the Mekk1 PHD substrate Carma within this pathway.\
(C) In vitro ubiquitination assays using Mekk1 PHD, Mekk1 mPHD, Ube2N:Ube2V1, E1, Ub, and Carma1. Reactions were performed as indicated and analyzed by IB as indicated. A fraction of the ubiquitination reactions was taken pre-incubation, boiled, analyzed by IB as shown, and indicated as input.\
(D) HEK293 cells were transfected with the indicated constructs. To detect in vivo ubiquitination, lysates were made under denaturing conditions for IP ([@bib15]) and IB performed as indicated. Lysates were also made under non-denaturing conditions as a loading control and IB performed with the indicated antibodies.\
(E) iNKT cells were isolated (four mice per experiment) and stimulated by TCR crosslinking with antibodies over a 60-min time course. To detect in vivo ubiquitination, lysates were made under denaturing conditions for IP ([@bib15]) and IB performed as indicated. Lysates were also made under non-denaturing conditions as a loading control and IB performed with the indicated antibodies.](gr3){#fig3}

![iNKT Cell Expansion in *Map3k1-*Deficient Mice\
(A) WT, *Map3k1*^*ΔKD*^, and *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice were i.p. injected with α-GalCer for 3 days. Splenocytes were harvested at days 0 and 3, stained with anti-TCRβ antibody and CD1d tetramer, and analyzed by flow cytometry as indicated. Data are representative of three independent experiments. Numbers in the profiles indicate the percentages of the gated populations.\
(B) Statistical analysis of α-GalCer-dependent iNKT expansion at days 0, 3, and 6 in *Map3k1*^*ΔKD*^ mice. The average percentage (±SEM) of PBS-57-loaded CD1d tetramer^+^ TCRβ ^+^ cells from five independent experiments is shown (black circle, WT; black square, *Map3k1*^*ΔKD*^ mice). Differences were analyzed by two-tailed Student's t test (^∗^p ≤ 0.05; ^∗∗^p ≤ 0.01; ^∗∗∗^p ≤ 0.001).\
(C) Liver cells were harvested at days 0 and 3 from WT, *Map3k1*^*ΔKD*^, and *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice following i.p. immunization with α-GalCer. Liver cells were stained with CD1d tetramer and anti-TCRβ antibodies and analyzed by flow cytometry as indicated. Data are representative of three independent experiments. Numbers in the profiles indicate the percentages of the gated populations.\
(D) Representative H&E-stained liver sections were prepared from unstimulated (upper panels) and 3-day α-GalCer stimulated (lower panels) WT, *Map3k1*^*ΔKD*^, and *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice (original magnification ×40; scale bar, 10 μM). Arrows indicate lymphocyte infiltration. Data are representative of three independent experiments (two mice per experiment).](gr4){#fig4}

![Mekk1 Signaling Controls p27^Kip1^ Expression to Regulate iNKT Cell Proliferation\
(A) WT and *Map3k1*^*ΔKD*^ mice were i.p. injected with α-GalCer for 3 days. RNA was isolated from WT and *Map3k1*^*ΔKD*^ splenic iNKT cells, processed, and hybridized onto Affymetrix arrays. Bioinformatics analysis was performed, and a heatmap comparing gene hits between WT and *Map3k1*^*ΔKD*^ iNKT cell microarray screens was constructed. The data are from three independent experiments (four mice per experiment).\
(B) Splenic and liver iNKT cells were isolated from 3-day α-GalCer-immunized *Lck*^*Cre/+*^*Map3k1*^*f/f*^, WT mice stained with anti-phospho c-Jun antibody, and flow cytometry performed as indicated (red line, WT; blue line, *Lck*^*Cre/+*^*Map3k1*^*f/f*^). Data were representative of three independent experiments. Histograms show the phospho c-Jun present in the gated iNKT cell population.\
(C) Splenic iNKT cells from 3-day α-GalCer-immunized *Lck*^*Cre/+*^*Map3k1*^*f/f*^ and WT mice were isolated and stained with anti-p27^Kip1^ antibody and flow cytometry performed as indicated (red line, WT; blue line, *Lck*^*Cre/+*^*Map3k1*^*f/f*^). Data were representative of three independent experiments. Histogram shows the p27^Kip1^ present in the gated iNKT cell population.\
(D) iNKT cells from the spleen and liver of WT and *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice were isolated 3 days post-i.p. injection with α-GalCer and their RNA analyzed by real-time PCR as indicated (gray square, WT; black square, *Lck*^*Cre/+*^*Map3k1*^*f/f*^). The average relative expression (±SEM) of genes from three independent experiments was statistically analyzed, where appropriate, by two-tailed Student's t test (^∗^p ≤ 0.05; ^∗∗^p ≤ 0.01; ^∗∗∗^p ≤ 0.001).\
(E) WT, *Map3k1*^*ΔKD*^, *Cdkn1b*^*−/−*^, or *Map3k1*^*ΔKD*^/*Cdkn1b*^*−/−*^ (DKO) mice were treated with water containing BrdU and i.p. immunized with α-GalCer (day 3) or left unstimulated (day 0). Splenocytes were extracted and analyzed as indicated. Representative results (±SEM) from three quantitated iNKT proliferation experiments were statistically analyzed, where appropriate, by two-tailed Student's t test (^∗^p ≤ 0.05; ^∗∗^p ≤ 0.01; ^∗∗∗^p ≤ 0.001).\
(F) WT, *Cdkn1b*^*−/−*^, *Map3k1*^*ΔKD*^, or *Map3k1*^*ΔKD*^/*Cdkn1b*^*−/−*^ (DKO) iNKT cells were isolated and incubated in \[^3^H\] thymidine containing media for 24 hr in the presence of DMSO (control), SP600125, PD98059, SB203580, NSC697923, or SU9516. The average cpm (±SEM) from three independent experiments was statistically analyzed, where appropriate, by two-tailed Student's t test (^∗^p ≤ 0.05; ^∗∗^p ≤ 0.01; ^∗∗∗^p ≤ 0.001).\
(G) WT, *Map3k1*^*ΔKD*^, and *Lck*^*Cre/+*^*Map3k1*^*f/f*^ mice were immunized with α-GalCer for 3 days, splenic or liver iNKT cells isolated, and *Cdkn1b* ChIP performed with anti-phospho c-Jun antibody as indicated. The average relative signal (±SEM) from three independent experiments was statistically analyzed, where appropriate, by two-tailed Student's t test (^∗^p ≤ 0.05; ^∗∗^p ≤ 0.01; ^∗∗∗^p ≤ 0.001).](gr5){#fig5}
